Top Tech Companies (2,157)
Rehab.com connects patients with providers who care.
Zylo provides a SaaS management platform designed to optimize cloud-based subscription.
Iodine is a new kind of healthcare company, with a mission to change medicine by helping people find what works best for them. We're based in San Francisco and believe in the power of people to make good decisions. The company was founded in 2013, and in Sept. 2014 launched our first product, an online resource on medication information and real-world experience with medications, based on a database of more than 100,000 reports from Americans. Since September 2013, Iodine has been the lead developer with the Food and Drug Administration on the openFDA research and development project. Everything we do is grounded in three truths: Data, Design, and Humanity. Data means that we start with science, and leverage technology to bring it to scale. We combine data from valid research including the FDA and Cochrane Reviews, and we capture new data that can generate new insights. We use design to build useful tools that work for real people, and to communicate serious information clearly and accurately. And we aim to serve real people in the real world, with empathy, respect, and honesty. Our mission is to experience into better medicine. Learn more by contacting us at [email protected]
Innovaccer Inc is a leading healthcare data activation platform company focused on delivering more efficient and effective healthcare through the use of pioneering analytics and transparent, clean, and accurate data. Innvoaccer’s aim is to simplify complex data from all points of care, streamline the information, and help organizations make powerful decisions and realize strategic goals based on key insights and predictions from their data. Its products have been deployed across more than 500 locations with over 10,000 providers leveraging it at institutions, governmental organizations, and several corporate enterprises such as Mercy ACO, StratiFi Health, Catalyst Health Network, Osler Health Network, and PHIX HIE. Innovaccer is based in San Francisco with offices around the United States and Asia.
As many of you know, we are excited to now be part of Vocera Communications. With our missions and visions aligned, this partnership will make a significant impact on care delivery. Just as our two companies have become one, so will our social media accounts. Please follow Vocera Communications to stay connected | https://www.linkedin.com/company/vocera-communications Extension Healthcare’s Engage™ “one platform” approach improves clinical communication, collaboration, care coordination, and workflow with a specific focus on reducing unnecessary clinical interruptions and improving response to critical patient events. With what is traditionally accomplished using several vendors and platforms, Extension combines comprehensive alarm management with secure communications on a single platform. The Extension platform intelligently notifies clinicians about real-time patient events through context-driven notifications to smartphones and other common mobile communication devices. Designed for enabling situational awareness and timely information sharing across care teams inside and outside the hospital, Engage aggregates alarm, patient, and care team data from a variety of systems including physiological monitors, nurse call and lab systems, Electronic Health Records (EHR), and location sensing technologies and sends relevant information to enhance the usefulness of alarm and alert notifications. Leveraging the common platform that is purpose built for extensive integration and data aggregation, the Engage Mobile secure texting solution helps to expedite care coordination in response to events. With proven integrations and interoperability in more than 200 hospitals, Extension Healthcare has become a leading solution for improving care quality and patient and caregiver experiences.
Marcia Brenner Associates provides software development, training, support and custom programming services.
Sajix Corporation recognized the need of integrated healthcare software system including Electronic Medical Record as well as Practice Management and we are in a position to deliver the need of healthcare through our innovative software platform. Sajix Inc (CCHIT certified), a California based Company is provider of web based integrated healthcare platform ("iHelix") offers (1) Practice Management (2) Electronic Medical record (3) Revenue cycle management (4) Other front office and back office process automation (5) Hospital Information System. We offer both license and Software-as-a-service model based on the customer choice. Our implementation time and cost is significantly less as our platform is highly configurable and can adapt to any kind of healthcare specialty delivery model. iHelix on Demand: iHelix relieves the clients from burden of hardware and software replacement or up gradation costs. Customers can just a pay per user fee and start using iHelix from our own high end secure servers leaving the maintenance and upgrades at Sajix. iHelix on Premises: Sajix implements iHelix at the customer data center offering the flexibility to run it on any relational database and giving full control of data to customers and to generate additional reports. Sajix also provides iHelix license to the customers, user support and maintenance. iHelix lite: iHelix lite is designed in accordance to the customers who works offline. iHelix lite provides solution for the mobile healthcare. Customers can save their daily work on their system and can later save it to the central server. For more information contact [email protected] at 925-218-7370 or visit our website at http://www.sajix.com/.
PracticeSuite's passion is providing money saving revenue cycle management tools to Practice Administrators, Medical Billers, and RCM Companies --in tandem with our certified physician EHR available +61 medical specialties. Our unique Money Pulse Monitor System™ alerts managers and physicians when revenue cycle best practices are overstepped and revenue leakage is about to occur. Rather than react to revenue loss days or weeks after it occurs, PracticeSuite’s proprietary RCM Technology puts you in ‘pro-action’ rather than reaction, to stop revenue loss before it happens. PracticeSuite is an end-to-end Cloud-based Medical Billing, Revenue Cycle Management, Electronic Health Record Software, Practice Portal, and Practice Marketing CRM Software. With clients nationwide, PracticeSuite’s all-in-one practice solution is currently used by 41,000 Office Managers, Medical Billers, Physicians and RCM Companies across 150 billing specialties and +61 clinical EHR specialties. Clients include solo practices, large medical groups, Medical Billing Companies, Technology Resellers, other EHR companies and other Billing Software companies. Based in the Silicon Valley, PracticeSuite is privately held and managed by seasoned healthcare technology professionals. It is profitable, debt free, and has grown every quarter since 2008. As a state of the art enterprise-class platform, PracticeSuite uses Linux, J2EE, HTML 5, Oracle and other evergreen open source technologies to manage the mission critical office needs of customers that rely on our platform to run their medical practices and businesses. At PracticeSuite, we believe that what is right for our customers is invariably right for us, so Customer Service is of paramount importance. We demonstrate this by listening intently to our users, and 100% of our software updates are based on client needs and our monthly release of new features continually meet their needs. Try our 100% free medical billing software.
Glooko is the leading remote patient monitoring platform for diabetes and is trusted by the world’s leaders in diabetes care. Glooko provides an FDA-cleared, HIPAA-compliant Web and Mobile application designed to improve health outcomes for people with diabetes, which in turn reduces costs for payers and the healthcare system. Glooko seamlessly syncs with over 150 diabetes devices and major fitness and activity trackers and supplies timely, verified patient data such as blood glucose, carbs, insulin, blood pressure, diet and weight data. Glooko’s mobile app enables patients to easily track and proactively manage all aspects of their diabetes care. Glooko’s population management web app and APIs offer diabetes-centric analytics and supplies insightful reports, graphs and risk flags to health systems and payers. Glooko's office upload product, powered by Diasend, makes office data upload and analysis easy and fast for clinicians.
With information spread across potentially thousands of health plans, health insurance companies need to quickly provide their members or providers with accurate health benefits information to avoid coverage confusion and more costly care. Sensentia’s proprietary artificial intelligence technology helps healthcare companies deliver an accurate, transparent, and simple customer experience by translating healthcare plan complexity into clear and meaningful information instantly and with near perfect accuracy. Sensentia technology powers customer service call centers and member self-service tools. Contact us to see a demonstration.
SutroVax is a biopharmaceutical company dedicated to the delivery of best-in-class conjugate vaccines and novel complex antigen-based vaccines to prevent serious infectious diseases. SutroVax’s lead product candidate is a pneumococcal conjugate vaccine (PCV) that is designed to prevent invasive pneumococcal disease (IPD) caused by Streptococcus pneumoniae. SutroVax’s broad-spectrum PCV is designed to provide expanded protection against circulating strains of pneumococcus and has the potential to replace the current vaccines used in infants and adults. The current mainstay vaccine only covers approximately 40% of the circulating strains causing IPD yet generates $6B in annual sales. SutroVax has generated positive pre-clinical proof-of-concept with its significantly broader-spectrum PCV compared head-to-head to current vaccines using well accepted immunological endpoints. In addition to its lead PCV product candidate, the Company also has a promising early-stage pipeline addressing other important disease areas. SutroVax’s conjugate vaccines are developed utilizing the Company’s exclusive rights to Sutro Biopharma’s Xpress CF Platform, a cell-free protein synthesis technology. SutroVax closed its $85M Series C round in May of 2018 and is financed by a world-class syndicate of private equity, venture capital and corporate venture investors with over $170M in capital raised since 2015.
Sensely is a digital health company powered by an avatar-based, empathy-driven clinical platform that helps clinicians and patients better monitor and manage their health. The Virtual Medical Assistant avatar is equipped with a set of remote diagnostic tools and leverages natural user interfaces to facilitate the assessment of a patient’s condition and provide insights for meaningful follow-up. Sensely provides access to high quality medicine by bringing back old-fashioned at home visits enabling billions to live better and thrive.
Arterys was founded to facilitate the global advancement of medicine through data, artificial intelligence and technology. Because a significant proportion of the world's medical data resides in medical images, Arterys set out to tackle several issues around the space, including the enormous workloads radiologists face, the lack of accuracy with many of today's tools, and the need for increased consistency across practices. The company was the first to receive FDA clearance for a cloud-based product with Artificial Intelligence, and currently has 5 FDA clearances, and is active in 28 countries. Arterys continues to focus solving some of radiology's most pressing needs. By making imaging diagnostics quantitative, intelligent and available, Arterys seeks to improve the lives of millions of patients. Arterys has offices in San Francisco, Calgary and Paris. For more information, please visit www.arterys.com. Follow Arterys on Twitter at @ArterysInc at https://twitter.com/ArterysInc.
hint® inc., the San Francisco-based company founded by entrepreneur Kara Goldin in 2005, is a healthy lifestyle brand known for its delicious unsweetened flavored water. In 2017 hint launched a sunscreen spray that's oxybenzone and paraben free and scented with hint fruit essences, finally making sunscreen application an enjoyable experience. After having her third child, Kara was overweight, had adult acne and was generally low energy. She realized the diet soda she was drinking daily was the culprit, and switched to water. She saw results quickly but hated the taste of plain water, so she started slicing up fruit and putting it in her water, which was just the hint of flavor she needed to make drinking water enjoyable. She knew there were lots of other consumers who were addicted to sugary drinks but plain water was too boring, and when she couldn't find a product on the shelves like the one she created in her kitchen, she decided to produce it herself. hint helps people fall in love with water by using real fruit essences to make it taste great without any calories, sweetener or additives. Today it is available in the original hint still water, hint fizz® (sparkling) and hint kick® (lightly caffeinated), and comes in many delicious flavors including Blackberry, Watermelon, Crisp Apple, Pineapple, Cherry and more. hint water can be found in stores all over the United States, or purchased online at www.drinkhint.com. hint is the fastest growing flavored water in the United States, and the largest beverage on campuses in Silicon Valley. The brand has received numerous accolades, including Best Flavored Water (from Health, Men’s Health, and SELF magazines). With the launch of sunscreen, hint has expanded beyond beverage into a trusted band known for solving consumer problems around health. hint has a strong team working across the country, and is headquartered in San Francisco.
Zylo provides a SaaS management platform designed to optimize cloud-based subscription.
Zylo provides a SaaS management platform designed to optimize cloud-based subscription.
Innovaccer Inc is a leading healthcare data activation platform company focused on delivering more efficient and effective healthcare through the use of pioneering analytics and transparent, clean, and accurate data. Innvoaccer’s aim is to simplify complex data from all points of care, streamline the information, and help organizations make powerful decisions and realize strategic goals based on key insights and predictions from their data. Its products have been deployed across more than 500 locations with over 10,000 providers leveraging it at institutions, governmental organizations, and several corporate enterprises such as Mercy ACO, StratiFi Health, Catalyst Health Network, Osler Health Network, and PHIX HIE. Innovaccer is based in San Francisco with offices around the United States and Asia.
Benchling makes life science research faster and more collaborative. Biotechnology has the potential to solve humanity’s most pressing challenges, such as disease, renewable energy, clean water, and hunger. The brightest minds are working on these problems but they are equipped with archaic tools. We aspire to fix this and increase the rate of scientific output with a web-based platform that allows researchers to design and run experiments, analyze data, and share results. Hundreds of thousands of scientists all around the world use Benchling to do research. Whether they are at the world’s largest companies, the top research universities, or working on a startup in a garage, scientists use Benchling for the same reason: to be empowered, not encumbered, by their tools. Read about the problems our engineers are solving: benchling.engineering Learn how our Customer Success Representatives work with cutting-edge biotech companies: blog.benchling.com/two-days-in-the-life-of-a-benchling-customer-success-manager Join our team: benchling.com/careers
TeraRecon is a leader in advanced visualization and artificial intelligence solutions. Our flagship product, iNtuition, is the market share leader for radiology and cardiology advanced visualization. Our AI division was also named the best new radiology vendor for 2018. We are committed to redefining advanced visualization by leveraging machine learning, and to improving radiology workflow through personalized automation that increases efficiency. TeraRecon is a privately-held global company with its world headquarters in Foster City, California, and major offices in Tokyo, Japan; Frankfurt, Germany; and Acton, MA; and Durham, NC. While our employees are located across the world, we work as one company, functionally-aligned, and goal-driven. TeraRecon’s transparency and collaborative work environment fosters an energetic and inviting culture
SutroVax is a biopharmaceutical company dedicated to the delivery of best-in-class conjugate vaccines and novel complex antigen-based vaccines to prevent serious infectious diseases. SutroVax’s lead product candidate is a pneumococcal conjugate vaccine (PCV) that is designed to prevent invasive pneumococcal disease (IPD) caused by Streptococcus pneumoniae. SutroVax’s broad-spectrum PCV is designed to provide expanded protection against circulating strains of pneumococcus and has the potential to replace the current vaccines used in infants and adults. The current mainstay vaccine only covers approximately 40% of the circulating strains causing IPD yet generates $6B in annual sales. SutroVax has generated positive pre-clinical proof-of-concept with its significantly broader-spectrum PCV compared head-to-head to current vaccines using well accepted immunological endpoints. In addition to its lead PCV product candidate, the Company also has a promising early-stage pipeline addressing other important disease areas. SutroVax’s conjugate vaccines are developed utilizing the Company’s exclusive rights to Sutro Biopharma’s Xpress CF Platform, a cell-free protein synthesis technology. SutroVax closed its $85M Series C round in May of 2018 and is financed by a world-class syndicate of private equity, venture capital and corporate venture investors with over $170M in capital raised since 2015.
